Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Duke Energy
DUK
|
+$172M |
| 2 |
Chevron
CVX
|
+$99.4M |
| 3 |
Apple
AAPL
|
+$91.7M |
| 4 |
Evergy
EVRG
|
+$89M |
| 5 |
Consolidated Edison
ED
|
+$86.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$412M |
| 2 |
Mondelez International
MDLZ
|
+$131M |
| 3 |
Johnson & Johnson
JNJ
|
+$107M |
| 4 |
NiSource
NI
|
+$88.5M |
| 5 |
PPL
PPL Corp
PPL
|
+$86.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.81% |
| 2 | Technology | 9.77% |
| 3 | Healthcare | 7.98% |
| 4 | Utilities | 7.37% |
| 5 | Real Estate | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Gevo
GEVO
$378M
| $49K | ﹤0.01% |
+23,680
| New | +$44.9K |
|
1427
PUT
Occidental Petroleum
OXY
$60B
| $49K | ﹤0.01% |
+1,000
| New | +$50.5K |
|
1428
Atea Pharmaceuticals
AVIR
$432M
| $46K | ﹤0.01% |
13,817
-1,926
| -12% | -$6.4K |
|
1429
News Corp Class B
NWS
$18.8B
| $43K | ﹤0.01% |
+1,407
| New | +$42.4K |
|
|
SGMO
1430
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $42K | ﹤0.01% |
+41,322
| New | +$75.5K |
|
1431
PUT
Devon Energy
DVN
$53.2B
| $39K | ﹤0.01% |
+1,200
| New | +$45.2K |
|
|
CWEN.A
1432
DELISTED
Clearway Energy Class A
CWEN.A
| $30K | ﹤0.01% |
1,210
-5,208
| -81% | -$135K |
|
1433
Aclaris Therapeutics
ACRS
$908M
| $26K | ﹤0.01% |
+10,637
| New | +$26.5K |
|
1434
iShares MSCI Brazil ETF
EWZ
$8.09B
| $23K | ﹤0.01% |
1,000
-1,401,262
| -100% | -$37.5M |
|
1435
Lennar Class B
LEN.B
$20.9B
| $6K | ﹤0.01% |
+44
| New | +$6.62K |
|
1436
U-Haul Holding Co
UHAL
$13.8B
| $4K | ﹤0.01% |
+52
| New | +$3.77K |
|
|
ALTM
1437
PUT
DELISTED
Arcadium Lithium plc
ALTM
| $4K | ﹤0.01% |
+700
| New | +$3.57K |
|
1438
American Airlines Group
AAL
$9.07B
| – | – |
-490,382
| Closed | -$7.05M |
|
1439
Applied Optoelectronics
AAOI
$9.32B
| – | – |
-11,383
| Closed | -$163K |
|
1440
Aaon
AAON
$6.19B
| – | – |
-32,299
| Closed | -$3.48M |
|
|
AAT
1441
American Assets Trust
AAT
$1.4B
| – | – |
-67,792
| Closed | -$1.81M |
|
1442
Ameris Bancorp
ABCB
$5.8B
| – | – |
-25,741
| Closed | -$1.61M |
|
1443
Asbury Automotive
ABG
$3.83B
| – | – |
-7,504
| Closed | -$1.79M |
|
1444
ABM Industries
ABM
$2.77B
| – | – |
-70,261
| Closed | -$3.71M |
|
1445
Abbott
ABT
$202B
| – | – |
-91,439
| Closed | -$10.4M |
|
1446
Arcosa
ACA
$7.13B
| – | – |
-22,464
| Closed | -$2.13M |
|
1447
Accel Entertainment
ACEL
$989M
| – | – |
-111,756
| Closed | -$1.3M |
|
1448
Acadia Healthcare
ACHC
$2.63B
| – | – |
-403,957
| Closed | -$25.6M |
|
1449
ACI Worldwide
ACIW
$5.28B
| – | – |
-125,365
| Closed | -$6.38M |
|
1450
Axcelis
ACLS
$3.79B
| – | – |
-95,475
| Closed | -$10M |
|
Similar funds
Michael Gelband's Q4 2024 Portfolio in Review
As of Q4 2024, Michael Gelband held 2,201 positions worth $14.6B, down 11% from $16.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Michael Gelband withdrew a net $1.86B in Q4 2024, closing 764 positions and reducing 361 holdings. Its most notable exit was Mondelez International, an estimated $131M position sold in full.
By sector, the portfolio is most concentrated in Financials at 9.8% of assets, up from 4.6% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Michael Gelband opened a new position in Duke Energy worth $164M.
- Michael Gelband's largest Q4 2024 buy was Duke Energy: 1,520,504 shares worth $164M.
- Michael Gelband added most to Chevron in Q4 2024, an estimated $99.4M increase.
- Michael Gelband's biggest Q4 2024 reduction was Microsoft, cutting an estimated $412M.
- Michael Gelband fully exited Mondelez International in Q4 2024, selling an estimated $131M.
- Michael Gelband's ten largest holdings make up 34% of its $14.6B portfolio in Q4 2024.
- Michael Gelband opened 633 new positions and closed 764 in Q4 2024.
- Michael Gelband's portfolio value fell 11% quarter-over-quarter to $14.6B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.